Apex Biotechnology Corp. announced earnings results for the full year ended December 31, 2018. For the full year, the company announced sales was TWD 2,043.614 million compared to TWD 1,795.300 million a year ago. Operating income was TWD 227.352 million compared to TWD 160.999 million a year ago. Net income was TWD 95.119 million compared to TWD 85.553 million a year ago. Basic earnings per share was TWD 0.95 compared to TWD 0.86 a year ago. Diluted earnings per share was TWD 0.9 compared to TWD 0.85 a year ago.